SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-047746
Filing Date
2023-02-24
Accepted
2023-02-24 09:19:58
Documents
14
Period of Report
2023-02-24
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d465819d8k.htm   iXBRL 8-K 47300
2 EX-3.1 d465819dex31.htm EX-3.1 6364
3 EX-3.2 d465819dex32.htm EX-3.2 70761
  Complete submission text file 0001193125-23-047746.txt   281747

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cinc-20230224.xsd EX-101.SCH 2835
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cinc-20230224_lab.xml EX-101.LAB 19482
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cinc-20230224_pre.xml EX-101.PRE 12143
8 EXTRACTED XBRL INSTANCE DOCUMENT d465819d8k_htm.xml XML 3659
Mailing Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451
Business Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451 8445311834
CinCor Pharma, Inc. (Filer) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41201 | Film No.: 23662719
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences